Related Experiment Video

Updated: May 26, 2026

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

TroVax(®) vaccine therapy for renal cell carcinoma

Rui-Tao Zhang1, Steven D Bines, Carl Ruby

  • 1Department of General Surgery, Rush University Medical Center, Chicago, IL, USA.

Immunotherapy
|December 14, 2011
PubMed

Insights

TroVax, a novel cancer vaccine targeting the 5T4 antigen, shows promise for renal cell carcinoma (RCC) treatment. Clinical trials evaluated its safety and efficacy, offering new immunotherapy options for kidney cancer.

Area of Science:

  • Oncology
  • Immunology
  • Vaccinology

Background:

  • Renal cell carcinoma (RCC) is the most common kidney malignancy.
  • Targeted therapies and immunotherapies (e.g., high-dose IL-2) have advanced RCC treatment.
  • Limited defined antigens in RCC have challenged specific vaccine development.

Purpose of the Study:

  • To discuss the clinical background of renal cell carcinoma (RCC).
  • To explain the rationale behind the development of the TroVax vaccine.
  • To review the clinical trial data and future directions for TroVax therapy in RCC.

Main Methods:

  • TroVax is a novel vaccine using a modified vaccinia virus Ankara vector to express the 5T4 tumor-associated antigen.
  • The 5T4 antigen is present in over 95% of clear cell and papillary RCC tumors.
  • Safety and efficacy evaluated in Phase I/II and Phase III clinical trials.

Main Results:

  • TroVax targets the 5T4 tumor-associated antigen, prevalent in RCC.
  • Clinical trials assessed the safety and efficacy of TroVax.
  • The vaccine represents a novel approach in RCC immunotherapy.

Conclusions:

  • TroVax is a novel vaccine targeting the 5T4 antigen, relevant to RCC.
  • Clinical trials have provided data on TroVax safety and efficacy.
  • Further research may optimize TroVax therapy for RCC and other cancers.

More Related Videos

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...